Sildalist 120mg is a dual-action oral medication formulated to address the medical condition of erectile dysfunction (ED) in adult men. It contains a combination of two potent phosphodiesterase type 5 (PDE5) inhibitors: Sildenafil Citrate (100mg) and Tadalafil (20mg). This unique pairing allows for a rapid onset of action with extended efficacy, catering to patients who experience difficulty achieving or maintaining a satisfactory erection during sexual activity. Due to its pharmacological potency, Sildalist is available only with a valid medical prescription.
Sildalist is indicated primarily for the treatment of erectile dysfunction, a common urological disorder characterized by the consistent inability to attain or sustain an erection adequate for intercourse. The combination therapy targets different pharmacokinetic timelines—Sildenafil acting quickly and Tadalafil providing longer-lasting support—making it beneficial for men seeking both immediate and sustained erectile function. This medication may also be considered in select cases of pulmonary arterial hypertension under specialist guidance, though this is off-label.
The active ingredients in this combination therapy work synergistically to enhance vasodilation in the corpus cavernosum of the penis. Sildenafil acts by selectively inhibiting the PDE5 enzyme, leading to increased levels of cyclic guanosine monophosphate (cGMP), which results in smooth muscle relaxation and augmented blood flow. Tadalafil, although mechanistically similar, exhibits a prolonged half-life, maintaining elevated cGMP levels over an extended period. Sexual stimulation remains a prerequisite for the pharmacodynamic effect.
While generally well-tolerated, Sildalist carries potential safety concerns, especially for individuals with pre-existing cardiovascular conditions. It is contraindicated in patients taking nitrate-based medications or alpha-blockers due to the risk of profound hypotension. Repeated or unsupervised usage may lead to psychological dependency, especially in individuals with performance anxiety. Long-term use without medical oversight is strongly discouraged. Always use under the guidance of a licensed healthcare provider.
Common adverse effects associated with this drug combination include headache, nasal congestion, facial flushing, dyspepsia, and dizziness. Rare but serious complications such as priapism, visual disturbances, or sudden hearing loss require immediate medical attention. The dual PDE5 inhibition may enhance side-effect intensity compared to monotherapy, necessitating individualized dosing and risk assessment.
Store Sildalist in its original packaging at a controlled room temperature between 15°C and 30°C. Protect from moisture and direct sunlight. Keep the tablets out of reach of children and do not use beyond the expiry date printed on the packaging. Do not refrigerate or freeze.
Sildalist 120mg combines two PDE5 inhibitors for enhanced erectile function support. Prescription-only and clinically potent, it requires cautious use under medical supervision to manage efficacy and minimize risk.
At Apotheekplus.net, we ensure your order gets to you safely and immediately.
If you place your order before 12:00 PM (Monday to Friday), we will dispatch it the same day, and most customers receive their package the following day.
Orders placed after 12:00 PM or over the weekend are processed on the next working day and usually arrive within 1–2 days.
You’ll get a tracking number via email once your order is on its way. Didn’t get an email? Please check your spam folder or reach out to our support team.
Please note that prescription medications cannot be returned due to health and safety regulations.
If your order arrives damaged or defective, don't hesitate to get in touch with our customer service within 48 hours. Our support team will guide you through the return process and assist in resolving any issues. Once the return has been received and verified, we will initiate your refund.
For more information, feel free to reach out to our customer service team at any time.